NO962859L - Bicykliske fibrinogen-antagonister - Google Patents

Bicykliske fibrinogen-antagonister

Info

Publication number
NO962859L
NO962859L NO962859A NO962859A NO962859L NO 962859 L NO962859 L NO 962859L NO 962859 A NO962859 A NO 962859A NO 962859 A NO962859 A NO 962859A NO 962859 L NO962859 L NO 962859L
Authority
NO
Norway
Prior art keywords
fibrinogen antagonists
bicyclic fibrinogen
bicyclic
antagonists
fibrinogen
Prior art date
Application number
NO962859A
Other languages
English (en)
Norwegian (no)
Other versions
NO962859D0 (no
Inventor
William Edward Bondinell
James Francis Callahan
William Francis Huffman
Richard Mccullough Keenan
Thomas Wen-Fu Ku
Kenneth Allen Newlander
James Martin Samanen
Irene Nijole Uzinskas
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO962859D0 publication Critical patent/NO962859D0/no
Publication of NO962859L publication Critical patent/NO962859L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
NO962859A 1994-01-07 1996-07-05 Bicykliske fibrinogen-antagonister NO962859L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17901194A 1994-01-07 1994-01-07
PCT/US1995/000248 WO1995018619A1 (fr) 1994-01-07 1995-01-09 Antagonistes de fibrinogene bicycliques

Publications (2)

Publication Number Publication Date
NO962859D0 NO962859D0 (no) 1996-07-05
NO962859L true NO962859L (no) 1996-09-05

Family

ID=22654859

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962859A NO962859L (no) 1994-01-07 1996-07-05 Bicykliske fibrinogen-antagonister

Country Status (26)

Country Link
US (1) US6117866A (fr)
EP (1) EP0738150B1 (fr)
JP (1) JPH09508620A (fr)
KR (1) KR100388772B1 (fr)
CN (1) CN1117569C (fr)
AP (1) AP542A (fr)
AT (1) ATE238993T1 (fr)
AU (1) AU699186B2 (fr)
BG (2) BG62844B1 (fr)
BR (1) BR9506499A (fr)
CZ (1) CZ292323B6 (fr)
DE (1) DE69530571T2 (fr)
DK (1) DK0738150T3 (fr)
ES (1) ES2197914T3 (fr)
HU (1) HUT76282A (fr)
IL (1) IL112243A (fr)
MA (1) MA23420A1 (fr)
NO (1) NO962859L (fr)
NZ (1) NZ279394A (fr)
OA (1) OA10368A (fr)
PT (1) PT738150E (fr)
SG (1) SG64884A1 (fr)
SK (1) SK86996A3 (fr)
TW (1) TW420682B (fr)
WO (1) WO1995018619A1 (fr)
ZA (1) ZA9545B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458784B1 (en) * 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
EP0762882A4 (fr) * 1994-06-29 2002-09-11 Smithkline Beecham Corp Antagonistes du recepteur de la vibronectine
EP0777657A1 (fr) * 1994-08-22 1997-06-11 Smithkline Beecham Corporation Composés bicycliques
DE19516483A1 (de) * 1995-05-05 1996-11-07 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
ZA9610853B (en) * 1995-12-29 1998-04-06 Smithkline Beecham Corp Processes and intermediates for preparing pharmaceuticals.
DE69723873T2 (de) 1996-09-03 2004-04-22 Smithkline Beecham Corp. Kristallines pharmazeutisches produkt
CN1246157A (zh) * 1996-12-27 2000-03-01 史密丝克莱恩比彻姆有限公司 用脂酶进行苯并二氮杂䓬－乙酸酯的酶拆分
AU745169B2 (en) * 1997-12-09 2002-03-14 Ihara Chemical Industry Co. Ltd. Process for producing toluene derivatives
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
WO2000035887A2 (fr) 1998-12-18 2000-06-22 Du Pont Pharm Co Medicaments antagonistes du recepteur de la vitronectine
US6569402B1 (en) 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
GB9908662D0 (en) * 1999-04-15 1999-06-09 Smithkline Beecham Plc Novel process for preparing benzodiazepines
CO5180550A1 (es) 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
CO5370679A1 (es) 1999-06-01 2004-02-27 Smithkline Beecham Corp Inhibidores fab 1
US6730684B1 (en) 1999-10-08 2004-05-04 Affinium Pharmaceuticals, Inc. Fab I inhibitors
ECSP003699A (es) 1999-10-08 2002-04-23 Smithkline Beecham Corp Inhibidores de fab i
US6762201B1 (en) 1999-10-08 2004-07-13 Affinium Pharmaceuticals, Inc. Fab I inhibitors
SE9904377D0 (sv) * 1999-12-01 1999-12-01 Astra Pharma Prod Pharmaceutical combinations
US6964974B2 (en) * 2000-09-08 2005-11-15 Hoffmann-La Roche Inc. 2,3-oxidosqualene-lanosterol cyclase inhibitors
DE60230934D1 (de) 2001-04-06 2009-03-05 Affinium Pharm Inc Fab-i-inhibitoren
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
KR20040058229A (ko) 2001-10-22 2004-07-03 더 스크립스 리서치 인스티튜트 항체 표적화 화합물
WO2004036181A2 (fr) * 2002-10-17 2004-04-29 The Trustees Of The University Of Pennsylvania Procede de traitement de maladies et de troubles neurologiques
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
ATE510174T1 (de) 2003-05-21 2011-06-15 Alexza Pharmaceuticals Inc Schlag gezündete unabhängige heizeinheit
GB0321256D0 (en) * 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
EP1677783A2 (fr) 2003-10-08 2006-07-12 Nicholas Piramal India Limited Antagonistes du recepteur du fibrinogene et leur utilisation
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
AU2004322756B2 (en) 2004-08-12 2011-04-14 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
US20070122408A1 (en) * 2005-10-20 2007-05-31 The Scripps Research Institute Fc Labeling for Immunostaining and Immunotargeting
EP2687533B1 (fr) 2006-07-20 2017-07-19 Debiopharm International SA Dérivés d'acrylamide en tant qu'inhibiteurs de FAB I
WO2008098374A1 (fr) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Sels, promédicaments et polymorphes d'inhibiteurs de fab 1
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
US8518927B2 (en) 2009-02-10 2013-08-27 The Scripps Research Institute Chemically programmed vaccination
KR101720885B1 (ko) 2012-06-19 2017-03-28 데비오팜 인터네셔날 에스 에이 (e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
RS61312B1 (sr) 2016-02-26 2021-02-26 Debiopharm Int Sa Lek za lečenje infekcija dijabetskog stopala
US12214118B2 (en) 2018-02-02 2025-02-04 Alexza Pharmaceuticals, Inc. Electrical condensation aerosol device
MY203711A (en) 2019-02-14 2024-07-15 Debiopharm Int Sa Afabicin formulation, method for making the same and uses thereof
JP7418475B2 (ja) 2019-06-14 2024-01-19 デバイオファーム インターナショナル エス．エー． バイオフィルムが関与する細菌感染症を治療するための医薬及びその使用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592552A (en) * 1976-12-10 1981-07-08 Inst Nat Sante Rech Med Pseudopeptides used as medicaments
LU77316A1 (fr) * 1977-05-11 1979-01-19
CA1145333A (fr) * 1980-02-08 1983-04-26 Quirico Branca Derives de benzodiazepine
CA1157855A (fr) * 1980-07-31 1983-11-29 Albert E. Fischli Derives de benzodiazepine
CA1163266A (fr) * 1980-07-31 1984-03-06 Albert E. Fischli Derives de benzodiazepine
NL8005133A (nl) * 1980-09-12 1982-04-01 Duphar Int Res Fenylpiperazinederivaten met antiagressieve werking.
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
ZA833214B (en) * 1982-05-12 1983-12-28 Hoffmann La Roche Bicyclic compounds
US5059688A (en) * 1982-06-14 1991-10-22 Hoechst-Roussel Pharmaceuticals Inc. 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepine preparation
DE3418271A1 (de) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach Neue benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US4820834A (en) * 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
EP0204349A3 (fr) * 1985-06-01 1990-01-03 Dr. Karl Thomae GmbH Dérivés d'amines hétéroaromatiques, médicaments les contenant et procédé pour leur préparation
ES2052595T3 (es) * 1986-12-15 1994-07-16 Inst Nat Sante Rech Med Nuevos derivados peptidicos y su aplicacion en especial en terapeutica.
DE3702755A1 (de) * 1987-01-30 1988-08-11 Hoechst Ag 3,5-di-tert.-butyl-4-hydroxybenzoesaeureamid, verschiedene von dessen derivaten, verfahren zur herstellung dieser verbindungen, die sie enthaltenden arzneimittel und ihre verwendung
AU639409B2 (en) * 1987-12-10 1993-07-29 La Jolla Cancer Research Foundation Conformationally stabilized cell adhesion peptides
DK107688D0 (da) * 1988-03-01 1988-03-01 Novo Industri As Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner
ZW6189A1 (en) * 1988-05-09 1990-05-09 Smithkline Beckman Corp Anti-aggregatory peptides
FR2634207B1 (fr) * 1988-07-12 1990-09-07 Synthelabo Derives de ((piperidinyl-4)methyl) benzazepines, leur preparation et leur application en therapeutique
US5039805A (en) * 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
EP0389189B1 (fr) * 1989-03-23 1994-05-18 Pfizer Limited Agents antiallergiques à base de diazépines
JPH04211071A (ja) * 1990-03-05 1992-08-03 Hokuriku Seiyaku Co Ltd 多環式化合物
IL99539A0 (en) * 1990-09-27 1992-08-18 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
IL99538A0 (en) * 1990-09-27 1992-08-18 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
IL99537A (en) * 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
EP0557406A4 (en) * 1990-11-01 1993-10-06 Smith-Kline Beecham Corporation -g(g)-turn peptidomimetics as fibrinogen antagonists
EP0559793A1 (fr) * 1990-11-30 1993-09-15 Smithkline Beecham Corporation Inhibiteurs de la protease du vih
US5321034A (en) * 1991-05-07 1994-06-14 Merck & Co., Inc. Fibrinogen receptor antagonists
EP0523845A3 (en) * 1991-06-14 1993-11-18 Merck & Co Inc New benzodiazepine analogs
EP0593603B1 (fr) * 1991-06-28 2002-11-20 Smithkline Beecham Corporation Antagonistes bicycliques de fibrinogene
US5250679A (en) * 1991-10-18 1993-10-05 Genentech, Inc. Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
US5663166A (en) * 1991-10-18 1997-09-02 Genentech, Inc. Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptor
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists
US5241065A (en) * 1992-02-25 1993-08-31 Schering Corporation 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity
RU2115650C1 (ru) * 1992-11-09 1998-07-20 Дзе Бутс Компани ПЛС 2,3,4,5-тетрагидро-1,4-бензотиазепины, их стереоизомеры или их фармацевтически приемлемые соли, способ их получения, фармацевтическая композиция, обладающая противосудорожным действием
NZ259802A (en) * 1992-12-21 1997-10-24 Smithkline Beecham Corp Bicyclic derivatives and pharmaceutical compositions
US5493020A (en) * 1993-07-29 1996-02-20 Genentech, Inc. Tricyclic inhibitors of the GPIIb IIIa receptor
EP0762882A4 (fr) * 1994-06-29 2002-09-11 Smithkline Beecham Corp Antagonistes du recepteur de la vibronectine

Also Published As

Publication number Publication date
NZ279394A (en) 1998-05-27
KR100388772B1 (ko) 2003-11-20
OA10368A (en) 2001-11-15
CN1143323A (zh) 1997-02-19
WO1995018619A1 (fr) 1995-07-13
CZ198196A3 (en) 1997-06-11
TW420682B (en) 2001-02-01
IL112243A (en) 1999-12-31
JPH09508620A (ja) 1997-09-02
AU1600195A (en) 1995-08-01
BG62844B1 (bg) 2000-09-29
ZA9545B (en) 1996-01-23
DE69530571T2 (de) 2004-03-04
HK1014668A1 (en) 1999-09-30
US6117866A (en) 2000-09-12
HUT76282A (en) 1997-07-28
EP0738150B1 (fr) 2003-05-02
SG64884A1 (en) 1999-05-25
DE69530571D1 (de) 2003-06-05
BG102863A (en) 1999-05-31
SK86996A3 (en) 1997-02-05
BR9506499A (pt) 1997-09-09
AU699186B2 (en) 1998-11-26
HU9601849D0 (en) 1996-09-30
WO1995018619A9 (fr) 2004-10-21
CN1117569C (zh) 2003-08-13
ES2197914T3 (es) 2004-01-16
EP0738150A4 (fr) 1997-03-19
IL112243A0 (en) 1995-03-30
PT738150E (pt) 2003-08-29
BG100698A (bg) 1997-02-28
ATE238993T1 (de) 2003-05-15
AP542A (en) 1996-10-01
NO962859D0 (no) 1996-07-05
AP9500710A0 (en) 1995-01-31
EP0738150A1 (fr) 1996-10-23
CZ292323B6 (cs) 2003-09-17
DK0738150T3 (da) 2003-08-25
MA23420A1 (fr) 1995-10-01

Similar Documents

Publication Publication Date Title
ATE238993T1 (de) Bicyclische fibrinogenantagonisten
EP0702671A4 (fr) Antagonistes bicycliques du fibrinogene
FI960156A7 (fi) Bentsyylioksikinuklidiinit aineet P antagonisteina
NO972526D0 (no) Tachykininantagonister
DE69719354D1 (de) Muscarin-antagonisten
FI946140L (fi) Diatsabisyklisiä neurokiniiniantagonisteja
FI943208L (fi) Bisyklisiä tetrahydropyratsolopyridiinejä
EP0866705A4 (fr) Antagonistes du recepteur de fibrinogene
FI954991A7 (fi) Bisyklisiä tetrahydropyrazolopyridiinejä
MX9101311A (es) Antagonistas receptores de fibrinogeno
EP0799189A4 (fr) Antagonistes bicycliques du fibrinogene
FI960516L (fi) Substituoituja bifenyylisulfonamidiendoteliiniantagonisteja
FI953916L (fi) Fibrinogeenireseptoriantagonisteja
EP0796252A4 (fr) Antagonistes du fibrinogene a cycle double
FI971177A7 (fi) Bisyklisiä karboksiamideja 5-HT1A-antagonisteina
BR1100543A (pt) antagonistas bicìclicos de fibrinogênio
SI0738150T1 (en) Bicyclic fibrinogen antagonists
KR970702876A (ko) 뉴로키닌 길항제(Neurokinine (tachykinine) antagonists)
LV10425A (lv) Fibrinogena receptoru antagonisti
ZA944019B (en) Bicyclic fibrinogen antagonists
ZA939515B (en) Bicyclic fibrinogen antagonists